[Neither the paper nor even the title of the paper seems to be available yet based on a quick search]...
Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions Christina...
An Alternative Approach to Future Diagnosis: Can Generalized Anxiety Disorder Be Distinguished From Major Depressive Disorder, Healthy People by...
Pediatric SARS-CoV-2 infection and development of anxiety and depression Dun-Dery, Frederick; Xie, Jianling; Zemek, Roger; Winston, Kathleen;...
The Association of Plasma Selenium and Selenoprotein P Levels with Depression Severity and Anxiety Symptoms Among Medical Students in Latvia...
Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021 Jinlei Zhou, Yuan Zhang, Shuangshuang He, Sen...
Blood Immuno-metabolic Biomarker Signatures of Depression and Affective Symptoms in Young Adults Nicholas Donnelly, Ruby Tsang, Èimear M Foley,...
Long-COVID and postural orthostatic tachycardia syndrome: a preliminary comparison of neuropsychological performance Aitana Ruiz de Lazcano,...
Investigating the Severity and Timeline of PASC Symptoms: Focus on Physiological and Cognitive Effects Rohan Melwani, Keerthana Noru, Sanya...
Abstract: Major depressive disorder (MDD) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) frequently occur together; yet their...
Immune Cell Exhaustion and Apoptotic Markers in Major Depressive Disorder: Effects of in Vitro Cannabidiol Administration. Muanpetch Rachayon,...
No Abstract Provided My phone isn’t letting me copy exerpts from pdf. But the reason I’m sharing this is it’s a rather interesting peak into how...
Association of inflammation cytokines with cognitive function in first-episode major depressive disorder Yanfang Wang, Yanqing Xi, Zongqi Wang,...
Abstract: Sufficient evidence is now available to accept the concept that the brain recognizes cytokines as molecular signals of sickness....
Interventions for the management of long covid post-covid condition: living systematic review Dena Zeraatkar; Michael Ling; Sarah Kirsh; Tanvir...
Depressive disorder; clinical correlates and Tumor Necrosis Factor alpha among post COVID-19 patients Aya Mohamed Khaled Sakr, Tarek Ahmed...
Insights into the Risk Factors and Outcomes of Post-COVID-19 Syndrome—Results from a Retrospective, Cross-Sectional Study in Romania Ioana Beja,...
Nuclear factor kappa-B cell NF-κB, interferon regulatory Factor, and glucocorticoid receptor pathway activation in major depressive Disorder: The...
FDA approves first app-based treatment for major depressive disorder https://time.com/7086622/depression-treatment-app-rejoyn/ The app, called...
Viral infections are increasingly recognized as triggers for depressive disorders, particularly following the SARS-CoV-2 pandemic and the rise of...
Separate names with a comma.
